| Authors: |
Anastasio NC; 1] Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA [2] Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA., Stutz SJ; 1] Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA [2] Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA., Fox RG; 1] Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA [2] Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA., Sears RM; Department of Psychiatry, Yale University, New Haven, CT, USA., Emeson RB; Center for Molecular Neuroscience, Department of Pharmacology, Vanderbilt University, Nashville, TN, USA., DiLeone RJ; Department of Psychiatry, Yale University, New Haven, CT, USA., O'Neil RT; Center for Molecular Neuroscience, Department of Pharmacology, Vanderbilt University, Nashville, TN, USA., Fink LH; 1] Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA [2] Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA., Li D; 1] Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA [2] Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA., Green TA; 1] Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA [2] Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA., Moeller FG; Department of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, VA, USA., Cunningham KA; 1] Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA [2] Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA. |
